Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 and/or 18 Positive Head and Neck Cancer
Clinical trial NCT05286060 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05286060
- Sponsor
- Yonsei University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2026-10-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.